Lanreotide autogel therapy in metastatic carcinoid tumour controlled by ultrasonography and tumour markers

Aim and background: Carcinoid tumours are rare progressive tumours that are sometimes associated with symptoms. These symptoms are responsive to treatment with somatostatin analogues lanreotide and octreotide. The prolonged release formulation lanreotide autogel was applied in our study controlled by different methods. We aimed to evaluate the benefit of lanreotide autogel to detect the extension of the tumour and to compare the benefit with other markers. Case report: The metastatic carcinoid tumour was detected during the surgical therapy. The 55 y old patient has undergone somatostatin receptor scintigraphy i…